» Articles » PMID: 27257997

Chronic Lung Allograft Dysfunction: A Systematic Review of Mechanisms

Overview
Journal Transplantation
Specialty General Surgery
Date 2016 Jun 4
PMID 27257997
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic lung allograft dysfunction (CLAD) is the major limitation of long-term survival after lung transplantation. Chronic lung allograft dysfunction manifests as bronchiolitis obliterans syndrome or the recently described restrictive allograft syndrome. Although numerous risk factors have been identified so far, the physiopathological mechanisms of CLAD remain poorly understood. We investigate here the immune mechanisms involved in the development of CLAD after lung transplantation. We explore the innate or adaptive immune reactions induced by the allograft itself or by the environment and how they lead to allograft dysfunction. Because current literature suggests bronchiolitis obliterans syndrome and restrictive allograft syndrome as 2 distinct entities, we focus on the specific factors behind one or the other syndromes. Chronic lung allograft dysfunction is a multifactorial disease that remains irreversible and unpredictable so far. We thus finally discuss the potential of systems-biology approach to predict its occurrence and to better understand its underlying mechanisms.

Citing Articles

Predicting Time to First Rejection Episode in Lung Transplant Patients Using a Comprehensive Multi-Indicator Model.

Chen Y, Li E, Yang Q, Chang Z, Yu B, Lu J J Inflamm Res. 2025; 18():477-491.

PMID: 39816954 PMC: 11734520. DOI: 10.2147/JIR.S495515.


Update on the immunological mechanisms of primary graft dysfunction and chronic lung allograft dysfunction.

Jeong J, Gelman A, Chong A Curr Opin Organ Transplant. 2024; 29(6):412-419.

PMID: 39422603 PMC: 11537820. DOI: 10.1097/MOT.0000000000001175.


Donor Fractions of Cell-Free DNA Are Elevated During CLAD But Not During Infectious Complications After Lung Transplantation.

Novo M, Norden R, Westin J, Dellgren G, Bohmer J, Ricksten A Transpl Int. 2024; 37:12772.

PMID: 39114640 PMC: 11303165. DOI: 10.3389/ti.2024.12772.


The gut microbiome in end-stage lung disease and lung transplantation.

Zhang S, Swarte J, Gacesa R, Knobbe T, Kremer D, Jansen B mSystems. 2024; 9(6):e0131223.

PMID: 38712927 PMC: 11237811. DOI: 10.1128/msystems.01312-23.


Macrophage and CD8 T cell discordance are associated with acute lung allograft dysfunction progression.

Calabrese D, Ekstrand C, Yellamilli S, Singer J, Hays S, Leard L J Heart Lung Transplant. 2024; 43(7):1074-1086.

PMID: 38367738 PMC: 11230518. DOI: 10.1016/j.healun.2024.02.007.